What We Do

Value & Access

Our talented teams focus on two key principles in delivering our value and access projects. Firstly, we deliver constructive strategic insight informed by our strong understanding of the ‘payer mindset’ and thorough comprehension of the clinical and health economic evidence supporting your product. Secondly, we place an emphasis on the quality of presentation and writing in our value and access materials. We believe that this combination is what leads to the most robust, compelling and effectively communicated value propositions.

Market Access

Strategically combining evidence through a multidisciplinary approach to create market access solutions

Health Technology Assessment

Strategic advice, technical understanding and high quality writing to address your HTA needs

Research

Value & Access Challenges

Alongside our work on client projects, we frequently conduct our own in-house research projects aimed at investigating and understanding challenges in the market access and value assessment space. For example, we frequently contribute to the ISPOR conference with research relating to HTA processes, health economic methods and broader market access issues for therapeutic products.

Learn More

Services We Offer

EU HTA Joint Clinical Assessment

Our Value and Access and Evidence Development teams are preparing for the upcoming implementation of the European Union’s Regulation on HTA in 2025. Learn how we could support you with your EU JCA needs.